Fluoxetine side effects first week

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Fluoxetine Side Effects in the First Week

Introduction to Fluoxetine

Fluoxetine, commonly known by its brand name Prozac, is a widely prescribed selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder, obsessive-compulsive disorder (OCD), and other conditions. Understanding the side effects during the initial phase of treatment is crucial for both patients and healthcare providers.

Common Side Effects in the First Week

Nervousness and Anxiety

One of the most frequently reported side effects of fluoxetine during the first week of treatment is an increase in nervousness and anxiety. This has been observed in various patient groups, including geriatric patients with major depressive disorder . These symptoms are generally mild and tend to diminish as the body adjusts to the medication.

Nausea

Nausea is another common side effect experienced by patients starting fluoxetine. This side effect is also noted in geriatric patients undergoing treatment for major depressive disorder . Like nervousness and anxiety, nausea typically subsides after the initial adjustment period.

Side Effects in Children and Adolescents

General Tolerability

In a study involving children and adolescents with OCD, fluoxetine was generally well tolerated. The most common side effects reported were mild and did not lead to discontinuation of the medication . This suggests that while side effects are present, they are manageable and do not outweigh the benefits of the treatment.

Conclusion

During the first week of fluoxetine treatment, patients may experience side effects such as nervousness, anxiety, and nausea. These side effects are generally mild and tend to decrease as the body adjusts to the medication. In children and adolescents, fluoxetine is well tolerated, with side effects being manageable. Understanding these initial side effects can help patients and healthcare providers better manage expectations and treatment plans.

Sources and full results

Most relevant research papers on this topic

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.

Fluoxetine is a generally safe and effective short-term treatment for children with obsessive-compulsive disorder.

RCT

1992·

300citations

·M. Riddle et al.

Journal of the American Academy of Child and Adolescent Psychiatry·

DOI

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.

Fluoxetine and doxepin both effectively improve major depressive symptoms in elderly patients, with fluoxetine showing fewer side effects and better tolerability.

RCT

1985·

165citations

·J. Feighner et al.

The Journal of clinical psychiatry

Behavioral Side Effects of Fluoxetine in Children and Adolescents

Fluoxetine treatment in children may cause behavioral side effects, which may be alleviated by dosage reduction or starting with lower doses.

Case Report

1990·

107citations

·M. Riddle et al.

Journal of Child and Adolescent Psychopharmacology·

DOI

A double‐blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients

Paroxetine shows comparable efficacy and tolerability with fluoxetine in treating major depression, but shows an earlier onset of action and reduced anxiety symptoms compared to fluoxetine.

RCT

1993·

118citations

·J. Wilde et al.

Acta Psychiatrica Scandinavica·

DOI

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

Chronic treatment with fluoxetine in major depression leads to a reciprocal pattern of subcortical and limbic decreases and cortical increases, suggesting brain adaptation in response to sustained serotonin reuptake inhibition.

2000·

1128citations

·H. Mayberg et al.

Biological psychiatry·

DOI

A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.

Both fluoxetine and amitriptyline effectively relieve depression symptoms, with fluoxetine showing slightly more side effects.

RCT

1985·

35citations

·J. Feighner

The Journal of clinical psychiatry

A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.

Fluoxetine effectively relieves symptoms of major depressive illness better than placebo and is better tolerated than imipramine, with the most common adverse experiences being drowsiness and excessive sweating.

RCT

1985·

139citations

·Cohn Jb et al.

The Journal of clinical psychiatry

Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects

Fluoxetine administration leads to selective depletion of gut microbiota, specifically Lactobacilli involved in body weight regulation, and increases the abundance of dysbiosis-related bacterial phylotypes.

Non-Randomized Exp.Rigorous Journal

2019·

77citations

·M. Lyte et al.

PeerJ·

DOI

The side effect profile and safety of fluoxetine.

Fluoxetine has a more frequent side effect profile of nausea, nervousness, and insomnia, but has few serious side effects and is generally well-tolerated in overdoses.

1985·

79citations

·J. Wernicke

The Journal of clinical psychiatry

Efficacy and Safety of Fluoxetine in the Treatment of Patients With Major Depression After First Myocardial Infarction: Findings From a Double-Blind, Placebo-Controlled Trial

Fluoxetine shows a trend favoring its use in treating post-MI depression, particularly in mild cases, and is safe for use beginning 3 months after the event.

RCT

2000·

246citations

·J. Strik et al.

Psychosomatic Medicine·

DOI

Try another search

lisinopril versus amlodipine

st johns wort uses

k56 medicine

what causes adhd in children

add or depression anxiety

dosage for lorazepam